CITIUS PHARMACEUTICALS INC (CTXR) Stock Income Statement
NASDAQ:CTXR - US17322U3068 - Common Stock
1.23 USD
+0 (+0.41%)
1.19 USD
-0.04 (-3.25%)
| TTM (2025-6-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 1.81M | 287.00K | N/A | N/A | N/A | |||
| Operating Expenses | 41.14M | 42.00M | 36.73M | 33.32M | 23.54M | |||
| Research and Development | 10.43M | 11.91M | 14.82M | 17.66M | 12.24M | |||
| Selling, General, and Administrative Expenses | 30.71M | 30.09M | 21.91M | 15.66M | 11.29M | |||
| Operating Income | -41.14M | -42.00M | -36.73M | -33.32M | -23.54M | |||
| Interest Income/Expense | 1.70K | 758.00K | 1.18M | 250.00K | 250.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 60.00K | |||
| Non Recurring Items | N/A | 2.39M | 3.59M | 0.00 | 170.00K | |||
| Income Before Taxes | -41.14M | -38.85M | -31.97M | -33.06M | -23.05M | |||
| Income Tax | 936.60K | 576.00K | 576.00K | 580.00K | N/A | |||
| Net Income | -40.99M | -40.19M | -33.69M | -33.64M | -24.51M | |||
| EBITDA | N/A | -41.79M | -36.54M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.97 | -5.97 | -5.57 | -0.23 | -0.23 | |||
| Non GAAP EPS | -4.96 | -4.40 | N/A | -0.22 | -0.27 | |||
| Statistics | ||||||||
All data in USD